SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Orthofix Medical Inc. – ‘10-Q’ for 6/30/20 – ‘EXCEL’

On:  Thursday, 8/6/20, at 8:20am ET   ·   For:  6/30/20   ·   Accession #:  1564590-20-37284   ·   File #:  0-19961

Previous ‘10-Q’:  ‘10-Q’ on 5/8/20 for 3/31/20   ·   Next:  ‘10-Q’ on 11/5/20 for 9/30/20   ·   Latest:  ‘10-Q’ on 11/8/23 for 9/30/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/06/20  Orthofix Medical Inc.             10-Q        6/30/20   81:10M                                    ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    969K 
 2: EX-10.2     Material Contract                                   HTML     96K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     31K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     27K 
12: R1          Document and Entity Information                     HTML     77K 
13: R2          Condensed Consolidated Balance Sheets               HTML    108K 
14: R3          Condensed Consolidated Balance Sheets               HTML     35K 
                (Parenthetical)                                                  
15: R4          Condensed Consolidated Statements of Income and     HTML    114K 
                Comprehensive Income (Loss)                                      
16: R5          Condensed Consolidated Statements of Changes in     HTML     75K 
                Shareholders' Equity                                             
17: R6          Condensed Consolidated Statements of Cash Flows     HTML    123K 
18: R7          Business, basis of presentation, COVID-19 update,   HTML     41K 
                and CARES Act                                                    
19: R8          Recently adopted accounting standards and recently  HTML     46K 
                issued accounting pronouncements                                 
20: R9          Acquisitions                                        HTML     93K 
21: R10         Inventories                                         HTML     46K 
22: R11         Leases                                              HTML    102K 
23: R12         Other current liabilities                           HTML     27K 
24: R13         Long-term debt                                      HTML     27K 
25: R14         Fair value measurements and investments             HTML    155K 
26: R15         Contingencies                                       HTML     29K 
27: R16         Accumulated other comprehensive loss                HTML     46K 
28: R17         Revenue recognition and accounts receivable         HTML    260K 
29: R18         Business segment information                        HTML    183K 
30: R19         Acquisition-Related Amortization and Remeasurement  HTML     55K 
31: R20         Share-based compensation                            HTML    108K 
32: R21         Income taxes                                        HTML     31K 
33: R22         Earnings per share ("Eps")                          HTML     69K 
34: R23         Subsequent Events                                   HTML     27K 
35: R24         Recently adopted accounting standards and recently  HTML     38K 
                issued accounting pronouncements (Policies)                      
36: R25         Acquisitions (Tables)                               HTML     92K 
37: R26         Inventories (Tables)                                HTML     47K 
38: R27         Leases (Tables)                                     HTML    102K 
39: R28         Fair value measurements and investments (Tables)    HTML    159K 
40: R29         Accumulated other comprehensive loss (Tables)       HTML     45K 
41: R30         Revenue recognition and accounts receivable         HTML    259K 
                (Tables)                                                         
42: R31         Business segment information (Tables)               HTML    180K 
43: R32         Acquisition-Related Amortization and Remeasurement  HTML     54K 
                (Tables)                                                         
44: R33         Share-based compensation (Tables)                   HTML    108K 
45: R34         Earnings per share ("Eps") (Tables)                 HTML     67K 
46: R35         Business, basis of presentation, COVID-19 update,   HTML     51K 
                and CARES Act - Additional information (Detail)                  
47: R36         Recently Adopted Accounting Standards and Recently  HTML     54K 
                Issued Accounting Pronouncements - Additional                    
                Information (Detail)                                             
48: R37         Acquisitions - Additional Information (Detail)      HTML     57K 
49: R38         Acquisitions - Summary of Fair Values of Assets     HTML     68K 
                Acquired and Liabilities Assumed (Detail)                        
50: R39         Inventories - Schedule of Inventories (Detail)      HTML     35K 
51: R40         Leases - Summary of Lease Portfolio (Detail)        HTML     52K 
52: R41         Leases - Summary of Supplemental Cash Flow          HTML     38K 
                Information Related to Leases (Detail)                           
53: R42         Leases - Additional Information (Detail)            HTML     37K 
54: R43         Other Current Liabilities - Additional Information  HTML     35K 
                (Detail)                                                         
55: R44         Long-Term Debt - Additional Information (Detail)    HTML     44K 
56: R45         Fair Value Measurements and Investments - Schedule  HTML     43K 
                of Financial Assets and Liabilities Measured at                  
                Fair Value on Recurring Basis (Detail)                           
57: R46         Fair Value Measurements and Investments -           HTML     50K 
                Additional Information (Detail)                                  
58: R47         Fair Value Measurements and Investments - Schedule  HTML     33K 
                of Reconciliation For Contingent Consideration                   
                Measured At Fair Value Using Significant                         
                Unobservable Inputs (Level 3) (Detail)                           
59: R48         Fair Value Measurements and Investments - Schedule  HTML     43K 
                of Valuation Methodology and Unobservable Inputs                 
                for Level 3 Assets and Liabilities Measured at                   
                Fair Value (Detail)                                              
60: R49         Fair Value Measurements and Investments - Schedule  HTML     38K 
                of Reconciliation of Debt Security and Warrant                   
                (Detail)                                                         
61: R50         Contingencies - Additional Information (Detail)     HTML     32K 
62: R51         Accumulated Other Comprehensive Loss - Components   HTML     36K 
                of Changes in Accumulated Other Comprehensive Loss               
                (Detail)                                                         
63: R52         Revenue Recognition and Accounts Receivable -       HTML     45K 
                Schedule of Net Sales by Major Product Category by               
                Reporting Segment (Detail)                                       
64: R53         Revenue Recognition and Accounts Receivable -       HTML     33K 
                Schedule of Components of Net Sales (Detail)                     
65: R54         Revenue Recognition and Accounts Receivable -       HTML     48K 
                Additional Information (Detail)                                  
66: R55         Revenue Recognition and Accounts Receivable -       HTML     97K 
                Schedule of Net Impact of Adoption to Balance                    
                Sheet (Detail)                                                   
67: R56         Revenue Recognition and Accounts Receivable -       HTML     34K 
                Schedule of Allowance for Expected Credit Losses                 
                (Detail)                                                         
68: R57         Business Segment Information - Additional           HTML     26K 
                Information (Detail)                                             
69: R58         Business Segment Information - Summary of EBIDTA    HTML     44K 
                by Reporting Segment (Detail)                                    
70: R59         Business Segment Information - Summary of Net       HTML     44K 
                Sales by Geographic Destination for Each Reporting               
                Segment (Detail)                                                 
71: R60         Acquisition-Related Amortization and Remeasurement  HTML     31K 
                - Components of Acquisition-Related Amortization                 
                and Remeasurement (Detail)                                       
72: R61         Share-based Compensation - Schedule of Components   HTML     47K 
                of Share-Based Compensation Expense (Detail)                     
73: R62         Share-based Compensation - Additional Information   HTML     26K 
                (Detail)                                                         
74: R63         Income Taxes - Additional Information (Detail)      HTML     42K 
75: R64         Earnings Per Share ("EPS") - Schedule of            HTML     39K 
                Reconciliation of Weighted Average Shares Used in                
                Diluted EPS (Detail)                                             
76: R65         Earnings Per Share ("EPS") - Additional             HTML     30K 
                Information (Detail)                                             
77: R66         Subsequent Events - Additional Information          HTML     43K 
                (Detail)                                                         
79: XML         IDEA XML File -- Filing Summary                      XML    151K 
11: XML         XBRL Instance -- ofix-10q_20200630_htm               XML   2.75M 
78: EXCEL       IDEA Workbook of Financial Reports                  XLSX     90K 
 7: EX-101.CAL  XBRL Calculations -- ofix-20200630_cal               XML    176K 
 8: EX-101.DEF  XBRL Definitions -- ofix-20200630_def                XML    561K 
 9: EX-101.LAB  XBRL Labels -- ofix-20200630_lab                     XML   1.14M 
10: EX-101.PRE  XBRL Presentations -- ofix-20200630_pre              XML    921K 
 6: EX-101.SCH  XBRL Schema -- ofix-20200630                         XSD    187K 
80: JSON        XBRL Instance as JSON Data -- MetaLinks              367±   562K 
81: ZIP         XBRL Zipped Folder -- 0001564590-20-037284-xbrl      Zip    212K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/26/21  Orthofix Medical Inc.             10-K       12/31/20  124:22M                                    ActiveDisclosure/FA
11/05/20  Orthofix Medical Inc.             10-Q        9/30/20   82:10M                                    ActiveDisclosure/FA
 9/14/20  Orthofix Medical Inc.             S-8         9/14/20    5:388K                                   ActiveDisclosure/FA


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/09/20  Orthofix Medical Inc.             8-K:5,7,9   6/08/20   12:212K                                   ActiveDisclosure/FA
Top
Filing Submission 0001564590-20-037284   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 2, 10:02:35.2pm ET